Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome

Isaac H. Liao, Blythe A. Corbett, Donald L. Gilbert, Silvia A. Bunge, Frank R Sharp

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Tourette Syndrome (TS) has been linked to both genetic and environmental factors. Gene-expression studies provide valuable insight into the causes of TS; however, many studies of gene expression in TS do not account for the effects of medication. Materials & methods: To investigate the effects of medication on gene expression in TS patients, RNA was isolated from the peripheral blood of 20 medicated TS subjects (MED) and 23 unmedicated TS subjects (UNMED), and quantified using whole-genome Affymetrix microarrays. Results: D2 dopamine receptor expression correlated positively with tic severity in MED but not UNMED. GABAA receptor subunit expression negatively correlated with tic severity in UNMED but not MED. Phenylethanolamine N-methyltransferase expression positively correlated with tic severity in UNMED but not MED. Conclusion: Modulation of tics by TS medication is associated with changes in dopamine, norepinephrine and GABA pathways.

Original languageEnglish (US)
Pages (from-to)1733-1741
Number of pages9
JournalPharmacogenomics
Volume11
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Tics
Tourette Syndrome
Gene Expression
Phenylethanolamine N-Methyltransferase
Dopamine D2 Receptors
GABA-A Receptors
gamma-Aminobutyric Acid
Dopamine
Norepinephrine
Genome
RNA

Keywords

  • GABRE
  • gene expression
  • microarray
  • NPAS4
  • phenylethanolamine N-methyltransferase
  • PNMT
  • Tourette Syndrome

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine

Cite this

Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome. / Liao, Isaac H.; Corbett, Blythe A.; Gilbert, Donald L.; Bunge, Silvia A.; Sharp, Frank R.

In: Pharmacogenomics, Vol. 11, No. 12, 12.2010, p. 1733-1741.

Research output: Contribution to journalArticle

Liao, Isaac H. ; Corbett, Blythe A. ; Gilbert, Donald L. ; Bunge, Silvia A. ; Sharp, Frank R. / Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome. In: Pharmacogenomics. 2010 ; Vol. 11, No. 12. pp. 1733-1741.
@article{d409fc4ba7544e2c8de7213dd36dbe20,
title = "Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome",
abstract = "Background: Tourette Syndrome (TS) has been linked to both genetic and environmental factors. Gene-expression studies provide valuable insight into the causes of TS; however, many studies of gene expression in TS do not account for the effects of medication. Materials & methods: To investigate the effects of medication on gene expression in TS patients, RNA was isolated from the peripheral blood of 20 medicated TS subjects (MED) and 23 unmedicated TS subjects (UNMED), and quantified using whole-genome Affymetrix microarrays. Results: D2 dopamine receptor expression correlated positively with tic severity in MED but not UNMED. GABAA receptor subunit expression negatively correlated with tic severity in UNMED but not MED. Phenylethanolamine N-methyltransferase expression positively correlated with tic severity in UNMED but not MED. Conclusion: Modulation of tics by TS medication is associated with changes in dopamine, norepinephrine and GABA pathways.",
keywords = "GABRE, gene expression, microarray, NPAS4, phenylethanolamine N-methyltransferase, PNMT, Tourette Syndrome",
author = "Liao, {Isaac H.} and Corbett, {Blythe A.} and Gilbert, {Donald L.} and Bunge, {Silvia A.} and Sharp, {Frank R}",
year = "2010",
month = "12",
doi = "10.2217/pgs.10.160",
language = "English (US)",
volume = "11",
pages = "1733--1741",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome

AU - Liao, Isaac H.

AU - Corbett, Blythe A.

AU - Gilbert, Donald L.

AU - Bunge, Silvia A.

AU - Sharp, Frank R

PY - 2010/12

Y1 - 2010/12

N2 - Background: Tourette Syndrome (TS) has been linked to both genetic and environmental factors. Gene-expression studies provide valuable insight into the causes of TS; however, many studies of gene expression in TS do not account for the effects of medication. Materials & methods: To investigate the effects of medication on gene expression in TS patients, RNA was isolated from the peripheral blood of 20 medicated TS subjects (MED) and 23 unmedicated TS subjects (UNMED), and quantified using whole-genome Affymetrix microarrays. Results: D2 dopamine receptor expression correlated positively with tic severity in MED but not UNMED. GABAA receptor subunit expression negatively correlated with tic severity in UNMED but not MED. Phenylethanolamine N-methyltransferase expression positively correlated with tic severity in UNMED but not MED. Conclusion: Modulation of tics by TS medication is associated with changes in dopamine, norepinephrine and GABA pathways.

AB - Background: Tourette Syndrome (TS) has been linked to both genetic and environmental factors. Gene-expression studies provide valuable insight into the causes of TS; however, many studies of gene expression in TS do not account for the effects of medication. Materials & methods: To investigate the effects of medication on gene expression in TS patients, RNA was isolated from the peripheral blood of 20 medicated TS subjects (MED) and 23 unmedicated TS subjects (UNMED), and quantified using whole-genome Affymetrix microarrays. Results: D2 dopamine receptor expression correlated positively with tic severity in MED but not UNMED. GABAA receptor subunit expression negatively correlated with tic severity in UNMED but not MED. Phenylethanolamine N-methyltransferase expression positively correlated with tic severity in UNMED but not MED. Conclusion: Modulation of tics by TS medication is associated with changes in dopamine, norepinephrine and GABA pathways.

KW - GABRE

KW - gene expression

KW - microarray

KW - NPAS4

KW - phenylethanolamine N-methyltransferase

KW - PNMT

KW - Tourette Syndrome

UR - http://www.scopus.com/inward/record.url?scp=78650393944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650393944&partnerID=8YFLogxK

U2 - 10.2217/pgs.10.160

DO - 10.2217/pgs.10.160

M3 - Article

C2 - 21142917

AN - SCOPUS:78650393944

VL - 11

SP - 1733

EP - 1741

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 12

ER -